Analgesic efficacy of collagen peptide in knee osteoarthritis: a meta-analysis of randomized controlled trials
A meta-analysis of 4 randomized controlled trials (507 patients) found collagen peptide supplementation produced a significant reduction in knee osteoarthritis pain versus placebo (SMD -0.58; moderate-quality evidence), with no significant difference in adverse events.
Evidence
6/10
Moderate Evidence
Sample
507
subjects
Duration
—
study period
Journal
Journal of Orthopaedic Surgery and Research
Sep 2023
Key Findings
- 01
4 RCTs, 507 patients with knee osteoarthritis
- 02
Significant pain reduction versus placebo (SMD -0.58, 95% CI -0.98 to -0.18)
- 03
No significant difference in adverse events versus placebo
Structured Methods
- Study Design
- Meta-Analysis
- Sample Size
- 507 subjects
- Study Duration
- Not reported
- Methodology
- Not reported
- Limitations
- Only 4 trials included; heterogeneity in collagen source/dose across studies; moderate rather than high certainty of evidence per GRADE.
Citations & References
Lin CR, Tsai SHL, Huang KY, Tsai PA, Chou H, Chang SH (2023). Analgesic efficacy of collagen peptide in knee osteoarthritis: a meta-analysis of randomized controlled trials. Journal of Orthopaedic Surgery and Research. https://doi.org/10.1186/s13018-023-04182-w
DOI
10.1186/s13018-023-04182-w
PubMed
37717022
Source
Publisher
Journal
Journal of Orthopaedic Surgery and Research
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation
